公司资料
PerkinElmer 股价、新闻与催化剂
- 股票代码:
- RVTY
- 交易所:
- NYSE
- 行业:
- MedTech
- 所在地:
- United States
股票表现
149.06 USD (-2.51%)
收盘价
最后更新: 2026年10月1日
11.2B USD
市值
股价为何变动
截至 2026年10月1日，RVTY 下跌 2.51%，收于 $149.06。当前新闻监测窗口内未发现新的同公司新闻。
公司概览
Health Science Tools and Diagnostics Company
Revvity provides technologies and services that support workflows from biological discovery through development and clinical diagnosis. Its customer base includes pharmaceutical and biotechnology companies, diagnostic laboratories, academic institutions, and government organizations.
Life Sciences Research Tools
The company offers imaging, detection, screening, automation, reagents, and assay technologies used in drug discovery and translational research. These tools help researchers study cells, proteins, genes, and disease mechanisms at multiple scales.
Translational Multi-Omics
Revvity's multi-omics capabilities combine genomic, transcriptomic, proteomic, and cellular analysis. The portfolio supports biomarker identification, target validation, and patient stratification across research and therapeutic-development workflows.
Diagnostics Portfolio
The diagnostics business supplies technologies for reproductive health, newborn screening, infectious disease, autoimmune testing, and other clinical applications. Instruments, assays, and laboratory software create recurring demand from regulated testing workflows.
Informatics and Workflow Integration
Revvity integrates laboratory informatics, data management, and analytics with its instruments and assays. This approach is intended to connect experimental data, automate interpretation, and improve continuity from discovery research to clinical use.
未来催化剂
近期新闻
新闻标题由机器翻译，详情为英文原文。
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。